This is not the most recent version of the article. View current version (11 NOV 2013)

Intervention Protocol

Human parathyroid hormone for the treatment of osteoporosis in post-menopausal women.

  1. Lisa M. Waldegger1,*,
  2. Ann Cranney2,
  3. Jonathan Adachi3,
  4. Peter Tugwell4,
  5. George A Wells5

Editorial Group: Cochrane Musculoskeletal Group

Published Online: 23 APR 2001

DOI: 10.1002/14651858.CD003111


How to Cite

Waldegger LM, Cranney A, Adachi J, Tugwell P, Wells GA. Human parathyroid hormone for the treatment of osteoporosis in post-menopausal women. (Protocol). Cochrane Database of Systematic Reviews 2001, Issue 2. Art. No.: CD003111. DOI: 10.1002/14651858.CD003111.

Author Information

  1. 1

    Health Canada, Public Health Agency of Canada, Ottawa, Ontario, Canada

  2. 2

    Ottawa Hospital, Division of Rheumatology, Ottawa, Ontario, Canada

  3. 3

    St Joseph's Hospital, Hamilton, Ontario, Canada

  4. 4

    Ottawa Hospital, Centre for Global Health, Institute of Population Health, Department of Medicine, Ottawa, Ontario, Canada

  5. 5

    University of Ottawa Heart Institute, Cardiovascular Research Reference Centre, Ottawa, Ontario, Canada

*Lisa M. Waldegger, Public Health Agency of Canada, Health Canada, 120 Colonnade Road, Ottawa, Ontario, K1A 0K9, Canada. lisa_pogany@phac-aspc.gc.ca.

Publication History

  1. Publication Status: Edited (no change to conclusions)
  2. Published Online: 23 APR 2001

SEARCH

This is not the most recent version of the article. View current version (11 NOV 2013)

 

Abstract

  1. Top of page
  2. Abstract

This is the protocol for a review and there is no abstract. The objectives are as follows:

To determine the efficacy of hPTH in the treatment of post-menopausal osteoporosis.